title: Reactivation of pulmonary tuberculosis during cancer treatment.
abstract: Reactivation of Mycobacterium tuberculosis can occur in patients with latent tuberculosis (TB) with risk factors including chronic disease (i.e., malignancy). We herein describe the case of an immigrant from Hong Kong with lung cancer and no known TB disease who presents with reactivation of TB in the setting of chemotherapy and radiation therapy.
authors.affiliation: Department of Medicine, Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA. Electronic address: Ramon.Jacobs@nyumc.org.
authors.forename: Ramon E A
authors.initials: RE
authors.lastname: Jacobs
authors.affiliation: Department of Medicine, Laura and Isaac Perlmutter Cancer Center, Division of Hematology and Medical Oncology, New York University School of Medicine, New York, NY, USA.
authors.forename: Ping
authors.initials: P
authors.lastname: Gu
authors.affiliation: Department of Medicine, Laura and Isaac Perlmutter Cancer Center, Division of Hematology and Medical Oncology, New York University School of Medicine, New York, NY, USA.
authors.forename: Abraham
authors.initials: A
authors.lastname: Chachoua
mesh_terms: D054242:Emigrants and Immigrants; D006723:Hong Kong; D006801:Humans; D055985:Latent Tuberculosis / Q000175:diagnosis* / Q000209:etiology / Q000382:microbiology; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000302:isolation & purification
keywords: Docetaxel; Lung cancer; Platinum-based chemotherapy; Radiation therapy; Solid-organ malignancy; Tuberculosis reactivation